Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMIOCAAF: Amiodarone vs Catheter Ablation in Persistent AF
NCT02341105Phase 4Terminated
- Sponsor
- Population Health Research Institute
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Population Health Research Institute. Primary endpoint: Composite outcome of hospitalization for cardiovascular cause or emergency department visit for atrial arrhythmia at 2 years. Started Jan 2016; status: terminated.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02341105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341105.